About Medigen Inc.
Medigen Inc. is a Pharmaceuticals company, headquartered in Frederick, with 51 - 200 employees and annual revenue of $1M - $5M.
Biopharmaceutical Company engaged in vaccine development against emerging viruses and biopharma CDMO manufacturing.
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Medigen Inc. Company Highlights
Phone Number
(301) 644-xxxx
Corporate Office Address
8420 Gas House Pike
Frederick, 21701
Website
Medigen Inc. Org
Medigen Inc. has 2 VP, 3 Director, 3 Manager, and 18 Other employees.
Medigen Inc. Decision Makers
- CEOPeter Pushko
Medigen Inc.'s Tech Stack
Frequently Asked Questions About
Medigen Inc.
Log in or sign up to get full contact details and additional support.
Who is the CEO of Medigen Inc.?
The CEO of Medigen Inc. is Peter Pushko. See full contact details ›
How many senior employees does Medigen Inc. have?
Medigen Inc. has 8 senior employees that are typically used for decision making.
Who are the key decision makers at Medigen Inc.?
Key decision makers at Medigen Inc. include Peter Pushko (CEO). See full contact details ›
What technologies does Medigen Inc. use?
Medigen Inc. uses technologies including Apache HTTP Server, Bluehost, and Chart.js.
How do I contact Medigen Inc.?
To contact Medigen Inc., visit medigen-usa.com.
What companies are similar to Medigen Inc.?
Companies similar to Medigen Inc. include IA, Advanced Clinical, and Fagron.
Where is Medigen Inc. headquartered?
Medigen Inc. is headquartered at 8420 Gas House Pike, Frederick.
What is the main phone number for Medigen Inc.?
The main phone number for Medigen Inc. is (301) 644-xxxx.
What is the official website for Medigen Inc.?
The official website for Medigen Inc. is medigen-usa.com.
What is the annual revenue of Medigen Inc.?
The annual revenue of Medigen Inc. is $1M - $5M.
How many employees does Medigen Inc. have?
Medigen Inc. has 51 - 200 employees.
What industry is Medigen Inc. in?
Medigen Inc. is in the Pharmaceuticals industry.
Last updated: July 22, 2025